Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Sell
41
TAP Quote, Financials, Valuation and Earnings
Last price:
$53.57
Seasonality move
:
3.02%
Day range:
$53.20 - $53.87
52-week range:
$49.19 - $64.66
Dividend yield:
3.34%
P/E ratio:
10.78x
P/S ratio:
0.98x
P/B ratio:
0.83x
Volume:
3.5M
Avg. volume:
2.7M
1-year change:
0.7%
Market cap:
$10.8B
Revenue:
$11.6B
EPS (TTM):
$4.97
Analysts' Opinion
-
Consensus RatingMolson Coors Beverage has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 14 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $63.15, Molson Coors Beverage has an estimated upside of 17.84% from its current price of $53.59.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $54.00 representing 100% downside risk from its current price of $53.59.
Fair Value
-
According to the consensus of 19 analysts, Molson Coors Beverage has 17.84% upside to fair value with a price target of $63.15 per share.
TAP vs. S&P 500
-
Over the past 5 trading days, Molson Coors Beverage has underperformed the S&P 500 by -3.14% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Molson Coors Beverage does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Molson Coors Beverage revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Molson Coors Beverage reported revenues of $2.3B.
Earnings Growth
-
Molson Coors Beverage earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Molson Coors Beverage reported earnings per share of $0.59.
Enterprise value:
17B
EV / Invested capital:
--
Price / LTM sales:
0.98x
EV / EBIT:
10.16x
EV / Revenue:
1.50x
PEG ratio (5yr expected):
0.45x
EV / Free cash flow:
15.51x
Price / Operating cash flow:
10.12x
Enterprise value / EBITDA:
6.96x
Gross Profit (TTM):
$4.4B
Return On Assets:
3.92%
Net Income Margin (TTM):
9.14%
Return On Equity:
7.7%
Return On Invested Capital:
5.22%
Operating Margin:
8.58%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $10.8B | $12B | $11.3B | $2.6B | $2.3B | |
| Gross Profit | $3.5B | $4.6B | $4.4B | $963.5M | $850.9M | |
| Operating Income | $940M | $1.7B | $1.7B | $308.9M | $197.7M | |
| EBITDA | $774.3M | $2.3B | $2.4B | $477.9M | $378M | |
| Diluted EPS | -$1.19 | $5.00 | $4.97 | $0.97 | $0.59 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.4B | $2.9B | $2.6B | $2.7B | $2.6B | |
| Total Assets | $27.2B | $27.7B | $25.9B | $26.1B | $25.9B | |
| Current Liabilities | $3.6B | $3.6B | $3.3B | $3.9B | $2.9B | |
| Total Liabilities | $14.3B | $14B | $12.9B | $12.7B | $12.5B | |
| Total Equity | $12.8B | $13.8B | $12.9B | $13.4B | $13.5B | |
| Total Debt | $8.2B | $7.3B | $6.6B | $6.2B | $6.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.6B | $2.1B | $1.8B | $25.4M | -$90.7M | |
| Cash From Investing | -$576.3M | -$876.8M | -$776.8M | -$212.5M | -$341.3M | |
| Cash From Financing | -$1.1B | -$1.1B | -$1.1B | -$216.2M | -$131.2M | |
| Free Cash Flow | $1B | $1.4B | $1.1B | -$189.3M | -$328M | |
TAP
Sector
Market Cap
$10.8B
$258.9M
Price % of 52-Week High
82.88%
75.55%
Dividend Yield
3.34%
0%
Shareholder Yield
7.7%
2.89%
1-Year Price Total Return
0.7%
-11.52%
Beta (5-Year)
0.734
0.392
Dividend yield:
3.34%
Annualized payout:
$1.76
Payout ratio:
35.88%
Growth streak:
4 years
Technicals
8-day SMA
Sell
Level
$54.42
200-day SMA
Sell
Level
$57.18
Bollinger Bands (100)
Sell
Level
54.71 - 60.15
Chaikin Money Flow
Buy
Level
22M
20-day SMA
Sell
Level
$55.42
Relative Strength Index (RSI14)
Sell
Level
35.99
ADX Line
Sell
Level
38.48
Williams %R
Neutral
Level
-76.2452
50-day SMA
Sell
Level
$57.82
MACD (12, 26)
Sell
Level
-1.13
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
104.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.6596)
Buy
CA Score
(Annual)
Level (0.0216)
Buy
Beneish M-Score
(Annual)
Level (-2.7208)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.1796)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Molson Coors owns well-known beer brands including Miller, Coors, Blue Moon, and Carling and ranks as the second-largest beer maker in both value and volume terms in the US, Canada, and the United Kingdom. Through licensing agreements, the firm also brews and distributes beer and hard seltzer under partner brands from Heineken, Anheuser-Busch InBev, Asahi, and Coca-Cola. The brewer uses independent distributors in the US, given the three-tier distribution requirements, while using a combination of distributors and an in-house sales team in Canada and Europe. North America remains its largest market, contributing over 80% of total revenue.
Stock Forecast FAQ
In the current month, TAP has received 4 Buy ratings 14 Hold ratings, and 1 Sell ratings. The TAP average analyst price target in the past 3 months is $63.15.
-
Where Will Molson Coors Beverage Stock Be In 1 Year?
According to analysts, the consensus estimate is that Molson Coors Beverage share price will rise to $63.15 per share over the next 12 months.
-
What Do Analysts Say About Molson Coors Beverage?
Analysts are divided on their view about Molson Coors Beverage share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Molson Coors Beverage is a Sell and believe this share price will drop from its current level to $54.00.
-
What Is Molson Coors Beverage's Price Target?
The price target for Molson Coors Beverage over the next 1-year time period is forecast to be $63.15 according to 19 Wall Street analysts, 4 of them rate the stock a Buy, 1 rates the stock a Sell, and 14 analysts rate the stock a Hold.
-
Is TAP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Molson Coors Beverage is a Hold. 14 of 19 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TAP?
You can purchase shares of Molson Coors Beverage via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Molson Coors Beverage shares.
-
What Is The Molson Coors Beverage Share Price Today?
Molson Coors Beverage was last trading at $53.57 per share. This represents the most recent stock quote for Molson Coors Beverage. Yesterday, Molson Coors Beverage closed at $53.59 per share.
-
How To Buy Molson Coors Beverage Stock Online?
In order to purchase Molson Coors Beverage stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
